Cargando…
Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?
Anaplastic lymphoma kinase (ALK) has been identified to exert a potent transforming activity through its rearrangement in non-small cell lung cancer (NSCLC), and patients (pts) with ALK rearrangement can be treated more successfully with ALK inhibitors, such as crizotinib, alectinib, and ceritinib,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661196/ https://www.ncbi.nlm.nih.gov/pubmed/26342831 http://dx.doi.org/10.1007/s10555-015-9592-y |